These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 9070242

  • 21. Cellular and endosomal insulin degradation.
    Duckworth WC, Hamel FG.
    Adv Second Messenger Phosphoprotein Res; 1990; 24():521-8. PubMed ID: 2119655
    [No Abstract] [Full Text] [Related]

  • 22. Insulin-degrading enzyme: stable expression of the human complementary DNA, characterization of its protein product, and chromosomal mapping of the human and mouse genes.
    Affholter JA, Hsieh CL, Francke U, Roth RA.
    Mol Endocrinol; 1990 Aug; 4(8):1125-35. PubMed ID: 2293021
    [Abstract] [Full Text] [Related]

  • 23. Regulation of insulin degradation: expression of an evolutionarily conserved insulin-degrading enzyme increases degradation via an intracellular pathway.
    Kuo WL, Gehm BD, Rosner MR.
    Mol Endocrinol; 1991 Oct; 5(10):1467-76. PubMed ID: 1775131
    [Abstract] [Full Text] [Related]

  • 24. [Insulin-like substance and insulin-degrading complex in hemolysates of human erythrocytes].
    Matuliavichius VA, Vareĭkis EI, Lashas LV.
    Biokhimiia; 1986 Feb; 51(2):278-84. PubMed ID: 3516229
    [Abstract] [Full Text] [Related]

  • 25. Insulin-degrading enzyme does not require peroxisomal localization for insulin degradation.
    Chesneau V, Perlman RK, Li W, Keller GA, Rosner MR.
    Endocrinology; 1997 Aug; 138(8):3444-51. PubMed ID: 9231799
    [Abstract] [Full Text] [Related]

  • 26. The insulysin (insulin degrading enzyme) enigma.
    Hersh LB.
    Cell Mol Life Sci; 2006 Nov; 63(21):2432-4. PubMed ID: 16952049
    [No Abstract] [Full Text] [Related]

  • 27. Retinoblastoma protein co-purifies with proteasomal insulin-degrading enzyme: implications for cell proliferation control.
    Radulescu RT, Duckworth WC, Levy JL, Fawcett J.
    Biochem Biophys Res Commun; 2010 Apr 30; 395(2):196-9. PubMed ID: 20362553
    [Abstract] [Full Text] [Related]

  • 28. An evolutionarily conserved TGF-alpha/insulin-degrading enzyme.
    Rosner MR.
    Mol Reprod Dev; 1990 Sep 30; 27(1):54-9. PubMed ID: 2271187
    [No Abstract] [Full Text] [Related]

  • 29. Hyperglycaemia and hyperinsulinaemia: is insulin-degrading enzyme the missing link?
    Fawcett J, Duckworth WC.
    Diabetologia; 2009 Aug 30; 52(8):1457-60. PubMed ID: 19504084
    [No Abstract] [Full Text] [Related]

  • 30. Extracellular insulin degrading activity creates instability in a CHO-based batch-refeed continuous process.
    Drapeau D, Luan YT, Popoloski JA, Richards DT, Cohen DC, Sinacore MS, Adamson SR.
    Cytotechnology; 1994 Aug 30; 15(1-3):103-9. PubMed ID: 7765921
    [Abstract] [Full Text] [Related]

  • 31. [The breakdown of insulin by the enzymes of animal and human cells].
    Sologub LI, Paskovskaia IS, Sukhorskaia IE.
    Probl Endokrinol (Mosk); 1990 Aug 30; 36(2):90-5. PubMed ID: 2194207
    [No Abstract] [Full Text] [Related]

  • 32. Studies on the insulin-degrading activity of rat liver plasma membranes.
    Scott GS, Thomas JH, Dron DI.
    Biochem Soc Trans; 1981 Feb 30; 9(1):127-8. PubMed ID: 6260545
    [No Abstract] [Full Text] [Related]

  • 33. Metabolism of a mutant insulin by a receptor-mediated process and an insulin degrading enzyme.
    Kobayashi M, Iwasaki M, Watanabe N, Ishibashi O, Takata Y, Haruta T, Sasaoka T, Shigeta Y, Inouye K.
    Diabetes Res Clin Pract; 1986 Feb 30; 2(5):257-62. PubMed ID: 3536368
    [Abstract] [Full Text] [Related]

  • 34. Identification of insulin-degrading enzyme on the surface of cultured human lymphocytes, rat hepatoma cells, and primary cultures of rat hepatocytes.
    Yokono K, Roth RA, Baba S.
    Endocrinology; 1982 Oct 30; 111(4):1102-8. PubMed ID: 6749484
    [No Abstract] [Full Text] [Related]

  • 35. Encapsulation of insulin for oral administration preserves interaction of the hormone with its receptor in vitro.
    Roques M, Damgé C, Michel C, Staedel C, Cremel G, Hubert P.
    Diabetes; 1992 Apr 30; 41(4):451-6. PubMed ID: 1607072
    [Abstract] [Full Text] [Related]

  • 36. Insulin-degrading activity in experimental liver cirrhosis of the rat.
    Auletta M, Antoniello S, Abrescia N.
    Enzyme Protein; 1992 Apr 30; 48(4):197-201. PubMed ID: 8821707
    [Abstract] [Full Text] [Related]

  • 37. [Biochemical characteristics of an initial degradation product of insulin by insulin-degrading enzyme].
    Yonezawa K.
    Nihon Naibunpi Gakkai Zasshi; 1988 Nov 20; 64(11):1140-56. PubMed ID: 2851464
    [Abstract] [Full Text] [Related]

  • 38. Immunohistochemical localization of insulin-degrading enzyme along the rat intestine, in the human colon adenocarcinoma cell line (Caco-2), and in human ileum.
    Chang LL, Stout LE, Wong WD, Buls JG, Rothenberger DA, Shier WT, Sorenson RL, Bai JP.
    J Pharm Sci; 1997 Jan 20; 86(1):116-9. PubMed ID: 9002470
    [Abstract] [Full Text] [Related]

  • 39. Inhibition of insulin degradation by hepatoma cells after microinjection of monoclonal antibodies to a specific cytosolic protease.
    Shii K, Roth RA.
    Proc Natl Acad Sci U S A; 1986 Jun 20; 83(12):4147-51. PubMed ID: 2424018
    [Abstract] [Full Text] [Related]

  • 40. Patterned artificial juxtacrine stimulation of cells by covalently immobilized insulin.
    Ito Y, Kondo S, Chen G, Imanishi Y.
    FEBS Lett; 1997 Feb 17; 403(2):159-62. PubMed ID: 9042958
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.